Net Cash Provided by (Used in) Financing Activities in USD of LUMOS PHARMA, INC. from 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Lumos Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2024.
  • Lumos Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$5K, a 98.4% increase year-over-year.
  • Lumos Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$576K, a 29.8% increase from 2022.
  • Lumos Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$821K, a 328% decline from 2021.
  • Lumos Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$192K, a 356% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

LUMOS PHARMA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$5K +$304K +98.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 -$309K -$291K -1617% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 -$18K +$148K +89.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q1 2021 -$166K -$166K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $0 +$46K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 -$46K +$178K +79.5% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q1 2018 -$224K +$4K +1.75% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 -$228K -$199K -686% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 -$29K -$14.7M -100% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q1 2015 $14.6M -$14M -48.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q1 2014 $28.6M -$20.4M -41.6% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-08-24
Q1 2013 $49M +$48.9M +62677% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $78K +$119K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 -$41K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10

LUMOS PHARMA, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$576K +$245K +29.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$821K -$629K -328% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$192K -$267K -356% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $75K +$53K +241% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $22K +$170K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 -$148K -$75.4M -100% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-03
2017 $75.3M +$73.4M +3898% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $1.88M -$21.2M -91.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
2015 $23.1M -$10.8M -31.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 $33.9M -$33.1M -49.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 $67M +$65.5M +4343% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $1.51M -$40.9M -96.4% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $42.4M +$31M +274% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 $11.3M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.